Search Results - "Campero, Rosalba Alonso"
-
1
Bioequivalence of Two Commercial Preparations of trimethoprim/sulfamethoxazole: A randomized, single-dose, single-blind, crossover trial
Published in Clinical therapeutics (01-02-2007)“…Abstract Background: Trimethoprinilsulfamethoxazole (TMP/SMX) is a combination of 2 antimicrobial agents that act synergistically, sequentially blocking 2…”
Get full text
Journal Article -
2
Experience with Epifast® cryopreserved epidermal allograft in the treatment of superficial and deep second-degree burns: Retrospective study of 297 cases, 2010–2015
Published in Burns open : an international open access journal for burn injuries (01-07-2019)“…The objective of this study was to describe our experience with Epifast cryopreserved epidermal allograft (CEA) in children with second degree burns. We…”
Get full text
Journal Article -
3
Safety of veralipride for the treatment of vasomotor symptoms of menopause
Published in Menopause (New York, N.Y.) (01-05-2014)“…OBJECTIVEVeralipride is a nonhormonal option for the treatment of vasomotor symptoms of menopause. Incidence of adverse events in a Mexican population and drug…”
Get full text
Journal Article -
4
Comparison of the Pharmacokinetics of a New 15-mg Modified-Release Tablet Formulation of Metoclopramide Versus a 10-mg Immediate-Release Tablet: A Single- and Multiple-Dose, Randomized, Open-Label, Parallel-Group Study in Healthy Mexican Male Volunteers
Published in Clinical therapeutics (01-05-2011)“…Abstract Background Metoclopramide is a prokinetic and antiemetic agent. Objective The goal of this study was to assess the pharmacokinetics of a new,…”
Get full text
Journal Article -
5
Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study
Published in Biomedicine & pharmacotherapy (01-12-2023)“…In both clinical and experimental trials, pirfenidone (PFD) showed anti-inflammatory and antifibrogenic effects. Considering the wide variation in hepatic…”
Get full text
Journal Article -
6
Improvement of quality of life and menopausal symptoms in climacteric women treated with low-dose monthly parenteral formulations of non-polymeric microspheres of 17β-estradiol/progesterone
Published in Gynecological endocrinology (02-10-2016)“…Objective: To evaluate the short term effect over menopausal symptoms and quality of life (QoL) of monthly parenteral formulations of 17β-estradiol…”
Get full text
Journal Article -
7
Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology
Published in Gynecological endocrinology (03-07-2015)“…Objective: To analyze the short-term efficacy and safety over menopausal symptoms of three low-dose continuous sequential 17β-estradiol (E)/progesterone (P)…”
Get full text
Journal Article -
8
Observational study of the local tolerability of injectable progesterone microspheres
Published in Gynecologic and obstetric investigation (01-01-2012)“…As intramuscular progesterone administration is associated with local intolerance, the purpose of this work was to determine the local tolerability of a new…”
Get more information
Journal Article -
9
Comparison of the pharmacokinetics of a new 30 mg modified-release tablet formulation of metoclopramide for once-a-day administration versus 10 mg immediate-release tablets: a single and multiple-dose, randomized, open-label, parallel study in healthy male subjects
Published in European journal of drug metabolism and pharmacokinetics (01-12-2012)“…The study aimed to assess the pharmacokinetics of a new, modified-release metoclopramide tablet, and compare it to an immediate-release tablet. A single and…”
Get full text
Journal Article